Y Intercept (Hong Kong) LTD Catalent, Inc. Transaction History

Y Intercept (Hong Kong) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$45.44 - $74.26 $139,500 - $227,978	3,070 New	3,070 $201,000
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $700,360 - $1.37 Million	-16,921 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$72.36 - $113.1 $1.22 Million - $1.91 Million	16,921 New	16,921 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $489,519 - $569,352	-4,094 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $446,941 - $582,780	4,094 New	4,094 $545,000
Q1 2021 May 12, 2021	SELL	$101.51 - $125.27 $296,815 - $366,289	-2,924 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$85.88 - $105.36 $251,113 - $308,072	2,924 New	2,924 $302,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.